About
Inversago Pharma Inc develops selective cannabinoid receptor 1 (CB1) blockers for treating metabolic and liver diseases without central nervous system side effects.
Explore Inversago Pharma Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.